vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.
PROSPERITY BANCSHARES INC is the larger business by last-quarter revenue ($367.6M vs $207.8M, roughly 1.8× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 31.6%, a 25.7% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
IDYA vs PB — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $367.6M |
| Net Profit | $119.2M | $116.3M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | — |
| Net Margin | 57.4% | 31.6% |
| Revenue YoY | — | — |
| Net Profit YoY | 330.1% | -10.7% |
| EPS (diluted) | $1.33 | $1.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $275.0M | ||
| Q3 25 | $207.8M | $273.4M | ||
| Q2 25 | — | $267.7M | ||
| Q1 25 | — | $265.4M | ||
| Q4 24 | — | $267.8M | ||
| Q3 24 | $0 | $261.7M | ||
| Q2 24 | $0 | $258.8M |
| Q1 26 | — | $116.3M | ||
| Q4 25 | — | $139.9M | ||
| Q3 25 | $119.2M | $137.6M | ||
| Q2 25 | — | $135.2M | ||
| Q1 25 | — | $130.2M | ||
| Q4 24 | — | $130.1M | ||
| Q3 24 | $-51.8M | $127.3M | ||
| Q2 24 | $-52.8M | $111.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 65.1% | ||
| Q3 25 | 52.2% | 64.4% | ||
| Q2 25 | — | 64.3% | ||
| Q1 25 | — | 62.7% | ||
| Q4 24 | — | 62.0% | ||
| Q3 24 | — | 62.1% | ||
| Q2 24 | — | 55.2% |
| Q1 26 | — | 31.6% | ||
| Q4 25 | — | 50.9% | ||
| Q3 25 | 57.4% | 50.3% | ||
| Q2 25 | — | 50.5% | ||
| Q1 25 | — | 49.1% | ||
| Q4 24 | — | 48.6% | ||
| Q3 24 | — | 48.6% | ||
| Q2 24 | — | 43.1% |
| Q1 26 | — | $1.16 | ||
| Q4 25 | — | $1.48 | ||
| Q3 25 | $1.33 | $1.45 | ||
| Q2 25 | — | $1.42 | ||
| Q1 25 | — | $1.37 | ||
| Q4 24 | — | $1.36 | ||
| Q3 24 | $-0.60 | $1.34 | ||
| Q2 24 | $-0.68 | $1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $8.2B |
| Total Assets | $1.2B | $43.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $786.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — |
| Q1 26 | — | $8.2B | ||
| Q4 25 | — | $7.6B | ||
| Q3 25 | $1.1B | $7.7B | ||
| Q2 25 | — | $7.6B | ||
| Q1 25 | — | $7.5B | ||
| Q4 24 | — | $7.4B | ||
| Q3 24 | $1.2B | $7.4B | ||
| Q2 24 | $931.7M | $7.3B |
| Q1 26 | — | $43.6B | ||
| Q4 25 | — | $38.5B | ||
| Q3 25 | $1.2B | $38.3B | ||
| Q2 25 | — | $38.4B | ||
| Q1 25 | — | $38.8B | ||
| Q4 24 | — | $39.6B | ||
| Q3 24 | $1.2B | $40.1B | ||
| Q2 24 | $973.7M | $39.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | — |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $78.3M | ||
| Q3 25 | $142.2M | $194.8M | ||
| Q2 25 | — | $98.2M | ||
| Q1 25 | — | $178.2M | ||
| Q4 24 | — | $-205.8M | ||
| Q3 24 | $-49.2M | $274.6M | ||
| Q2 24 | $-32.9M | $216.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $68.5M | ||
| Q3 25 | $142.2M | $185.7M | ||
| Q2 25 | — | $91.8M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $-210.7M | ||
| Q3 24 | $-49.7M | $270.2M | ||
| Q2 24 | $-33.9M | $211.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 24.9% | ||
| Q3 25 | 68.4% | 67.9% | ||
| Q2 25 | — | 34.3% | ||
| Q1 25 | — | 64.5% | ||
| Q4 24 | — | -78.7% | ||
| Q3 24 | — | 103.3% | ||
| Q2 24 | — | 81.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.6% | ||
| Q3 25 | 0.0% | 3.3% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.56× | ||
| Q3 25 | 1.19× | 1.42× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 1.37× | ||
| Q4 24 | — | -1.58× | ||
| Q3 24 | — | 2.16× | ||
| Q2 24 | — | 1.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
